Market Overview

UPDATE: JP Morgan Raises PT to $62 on Health Care REIT Post Q2

Share:
Related HCN
7 Biggest Price Target Changes For Friday
10 Notable Stocks Trading Ex-Dividend Friday, November 4

JP Morgan reiterated its Overweight rating on Health Care REIT (NYSE: HCN) and increased its price target from $61 to $62.

JP Morgan commented, "Our OW rating on HCN is based on a number of factors including our belief that the stock has above-average growth prospects relative to the health care sector, and we see valuation attractive based on discounted trading multiples and an above-average dividend yield."

Health Care REIT closed at $60.17 on Thursday.

Latest Ratings for HCN

DateFirmActionFromTo
Jan 2017SunTrust Robinson HumphreyDowngradesBuyHold
Jan 2017Mitsubishi UFJUpgradesNeutralOverweight
Dec 2016Wells FargoDowngradesOutperformMarket Perform

View More Analyst Ratings for HCN
View the Latest Analyst Ratings

Posted-In: JP MorganAnalyst Color Price Target Reiteration Intraday Update Analyst Ratings

 

Related Articles (HCN)

View Comments and Join the Discussion!